Indoco Remedies

INDOCO02 May 2024
Pharmaceuticals
₹
+4.75 (+1.45%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Indoco Remedies
Indoco Remedies
Pharmaceuticals
INDOCO02 May 2024
₹
+4.75 (+1.45%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Indoco Remedies - Share Price & Details

Lowest Today
326
Highest Today
334.45
Today’s Open
328.1
Prev. Close
326.95
52 Week High
415
52 Week Low
308.3
Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
1.49%
Upper Circuit
Lower Circuit
P/E TTM
27.27
P/B Ratio
2.83
Traded Value(Cr)
0.00
EPS TTM
11.99
Book value
Dividend
0.69%

Price Performance

-0.76 %
1 Wk
-3.64 %
1 M
-11.05 %
3 M
1.49 %
1 Y
-16.22 %
YTD

Traded Volume Movement

Technical Details

Support 3
319
Support 2
323
Support 1
327
Pivot Point :
331
Resistance 1
336
Resistance 2
340
Resistance 3
344

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Indoco Remedies Ltd
₹331.70(+4.75/1.45%)
331.70+4.753,013.901.4927.272.83
Lupin Ltd
₹1,643.95(-1.95/-0.12%)
1,643.95-1.9575,011.91132.2136.393.89
Ipca Laboratories Ltd
₹1,349.70(+10.20/0.76%)
1,349.70+10.2033,983.6889.1061.695.47
J B Chemicals & Pharmaceuticals Ltd
₹1,876.00(-29.25/-1.54%)
1,876.00-29.2529,568.4983.2058.3711.01
Sanofi India Ltd
₹8,660.10(+334.55/4.02%)
8,660.10+334.5519,173.7453.4132.4618.88
IOL Chemicals & Pharmaceuticals Ltd
₹392.40(-1.30/-0.33%)
392.40-1.302,311.24-3.8713.461.46

About Indoco Remedies Ltd

Indoco Remedies Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 3014.36 crores. It has reported a sales of Rs. 448.38 crores and a net profit of Rs. 20.01 crores for the quarter ended December 2018. The company management includes Suresh G Kare, Suresh G Kare,Aditi Kare Panandikar,Sundeep V Bambolkar,Rajiv Kakodkar,D M Gavaskar,Vasudha V Kamat,Abhijit Y Gore,Anand Nadkarni,Ajay Mulgaokar,Satish Shenoy (Indoco Remedies Ltd) among others.
Chairman
Suresh G Kare
Registered office
Indoco House 166 C S T Road,Santacruz (East) Kalina,Mumbai,Maharashtra,400098
FAX :91-022-26520787
Background
Incorporation Year1947
Face Value₹2
Market Lot1

Latest News

Can Nifty 50 climb to 23K this week after US Fed downplaying rate hike buzz
Indian stock market today: Global equities witnessed a strong rebound after the US Fed meeting, which signaled a willingness to go for a rate cut once there is an ease in the inflation concerns. On Dalal Street, the frontline Indian indices and broad market witnessed buying interest during morning deals, which are still underway. However, the Nifty 50 index is somehow not able to breach.
02 May 2024 | 12:51 PM
📢 Benchmark indices open on a flat note today; Nifty near 22,650
📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 150.34 points or 0.20% at 74,633.12 and the Nifty was up 50.10 points or 0.22% at 22,654.95.
📢 Indiamart Intermesh (⬆️4.15%), Cholamandalam Investment and Finance Company (⬆️3.73%) and Hindustan Petroleum (⬆️3.54%) appeared as the top performers on the Nifty50 at open.
02 May 2024 | 09:24 AM
📢 Benchmark indices open on a flat note today; Nifty near 22,650
📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 150.34 points or 0.20% at 74,633.12 and the Nifty was up 50.10 points or 0.22% at 22,654.95.
📢 Indiamart Intermesh (⬆️4.15%), Cholamandalam Investment and Finance Company (⬆️3.73%) and Hindustan Petroleum (⬆️3.54%) appeared as the top performers on the Nifty50 at open.
02 May 2024 | 09:24 AM
Morgan Stanley, India Life Sciences funds acquire control of Maiva Pharma
Maiva Pharma, an injectables contract development and manufacturing organisation (CDMO), has raised about Rs 1,000 crore in primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund-IV, the company said. The two investors have jointly acquired a controlling stake in Maiva from existing investors and have infused primary capital.
02 May 2024 | 03:30 PM
Buy InterGlobe Aviation; target of Rs 4700: Emkay Global Financial
Emkay Global Financial's research report on InterGlobe AviationThe stock, despite its recent strong runup, still has legs, given that competitors Air India/Akasa’s order books have higher exposure to Boeing (737 Max, facing safety issues) which implies risk to their near-term capacity adds. Indigo, backed by a steady stream of Airbus deliveries, can gain mkt share & improve yields.
02 May 2024 | 03:27 PM
view more news

How to buy Indoco Remedies shares on nse?

To buy Indoco Remedies shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Indoco Remedies share price today?

The Indoco Remedies shares price on nse is Rs.331.7 today.

What is the market cap of Indoco Remedies shares on NSE ?

The company has a market capitalization of Rs.3013.90Cr

What is the PE & PB ratio of Indoco Remedies shares ?

PE is 27.27 and PB is 2.83

What is the 52 Week High and Low of Indoco Remedies shares?

Indoco Remedies stock price high: Rs.415 Indoco Remedies stock price low: Rs.308.3
BUY
SELL